Vancouver, BC, August 18th, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) reports that it has issued an aggregate of 1,400,275 common shares to certain shareholders, including directors, officers, and consultants.

A total of 1,139,275 common shares were converted from 113,926 Class A Preferred Shares on a ten to one basis. The common shares were issued as a result of the Company achieving certain EBITDA milestones pursuant to an escrow agreement dated December 19, 2014 and amended on March 8, 2015. Pursuant to the share purchase agreement dated March 4, 2015, with Prestige Worldwide Holdings Inc., 261,000 common shares were issued following the achievement of certain
EBITDA milestones as outlined in the agreement.

About Invictus MD Strategies Corp.
Invictus MD targets companies with proven brands, strong customer focus, and significant growth potential. We not only provide capital to meet these objectives but also years of management experience from a team that has been successful in all facets of business from start-ups to running large international organizations. The fundamental core of our operations is centered on the vast opportunities within fragmented industries. Invictus MD works in partnership with management teams to increase shareholder value through business planning and process integration, developing and executing growth strategies, leveraging our experience and relationships, and structuring and deploying the proper capital to support long-term growth. Our prudent approach to both investing in and developing successful companies ensures successful execution of the business plan in both times of economic expansion and contraction.

For more information please visit

On Behalf of the Board,

Dan Kriznic

Chairman & CEO